SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : Stem Cell Research -- Ignore unavailable to you. Want to Upgrade?


To: SnowShredder who wrote (375)10/4/2007 6:18:58 PM
From: SnowShredder  Respond to of 495
 
"CELLERIX GRANTS AXCAN RIGHTS TO Cx401 IN NORTH AMERICA
Reaching up to $40 million in upfront and milestones, this is the first and largest ever licensing deal involving a stem cell product in late stage clinical development"<snip>...

fwiw...

Message 23937709

Best of Luck,

SS